chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Laboratory test abnormal, Unevaluable event
Clinical narrative: Information has been received from a registered nurse concerning a 19 year old female with no allergies or medical history who on 18-APR-1987 and 14-MAY-1997 was vaccinated with a first and second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccines on 14-MAY-1997 included a dose of hepatitis B virus vaccine rHBsAg (yeast).
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning a female with an allergy to PCN who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live as a child.  It was noted that a titer done this summer was negative.  No further information was available regarding the adverse event.  It was reported that the adverse event did not improve and the patient is not recovered.  There was no  product quality complaint reported.  The patient sought unspecified medical attention.  Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: MMR
Symptoms: Erythema, Rash
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 15-month-old healthy white male with no medical history or drug allergies who on 24-MAY-2005, at 13:00, was vaccinated IM with the first 0.5ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  There were no concomitant therapy.  The RN reported that on 01-JUN-2005, the patient developed a measles rash all over the his body.  The measles rash was noted to be pinpoint in nature, erythematous and "blanches".  There were no vesicles.  The patient was afebrile, had a good appetite and was acting normally.  Unspecified medical attention was sought, but no laboratory/diagnostic test  were performed.  As of 07-JUN-2005, at an office visit, the patients' measles rash was considered to be resolved.  Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Coma, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 12 month old Asian female who on 22-AUG-2005, at 12:00 PM, was vaccinated in the left arm with a 1st dose of MMRII (lot 647563/0578R). Concomitant therapy included a 1st dose, in the right arm, of varicella virus vaccine live (lot 651044/0323R). There were no other concomitant medications and no illness at the time of vaccination. On 8/23/05, at 17:00 PM, the pt experienced a fever greater than 105F and was unresponsive. There was no infectious cause identified on the visit to the ER. No additional info was provided. Additional info has been requested.
Sex: U
Vaccine: MMR
Symptoms: Basedow's disease
Clinical narrative: Info has been received regarding a case in litigation from a physician concerning a pt who was vaccinated with MMRII and developed Graves Disease or sub-acute thyroiditis post/vax. It was unknown whether the pt sought medical attention. It was noted that the physician reported, "the pt was not vaccinated in his office, as no adverse event". The physician reported he has no other info on the pt. There was no product quality complaint reported. No additional info has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Cellulitis
Clinical narrative: Information has been received from a health professional concerning a 4 year old male with no pertinent medical history and no known drug reactions or allergies, who on 25-AUG-2005 was vaccinated subcutaneously with 0.5 cc of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccinations given on an unspecified date included poliovirus vaccine and diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid.  On 27-AUG-2005 the child developed cellulitis on the left leg.  Unspecified medical attention was sought, and the child was treated with amoxicillin (+) clavulanate potassium (AUGMENTIN) and loratadine (CLARTIN).  At the time of this report, the outcome of cellulitis was unknown.  Additional information has been requested.
Age: 1.45
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site swelling, Urticaria
Clinical narrative: Info has been received from a CMA concerning a 17 month old white female with no medical history or allergies, who on 8/30/05 was vaccinated, SC, into the right thigh with a dose of MMRII (lot 647652/0579R). There was no illness at the time of vaccination. There was no concomitant medication. On 8/30/05, 5 minutes after vaccination, the pt developed 1 cm sized hives under her right eye. The pt also developed a 7 cm blotch at the injection site with redness and swelling. The pt was treated with Benadryl and all events improved. It was noted that the pt was referred to an allergist. There were no lab/diagnostic studies performed. Subsequently, the pt recovered. No product quality complaint was involved. Additional info is not expected.
Age: 1.08
Sex: F
Vaccine: MMR
Symptoms: Asthenia, Erythema, Pyrexia, Rash, Rash papular
Clinical narrative: Information has been received from a physician and a nurse practitioner (NP) concerning a 13-month-old white female with no known allergies who in approximately March 2002 was vaccinated with the first dose of measles virus vaccine live(+) mumps virus vaccine live (+) rubella virus vaccine live. The physician reported that, eight days after being vaccinated, in approximately April 2002 the patient developed a high fever and rash and was subsequently hospitalized.  Subsequently, the patient's high fever and rash resolved.  On 29-AUG-2005, at approximately 10:00, at 4.5 years of age, the patient was vaccinated SC in the right arm with the second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccinations on that same day included a dose of Diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid.  There was no illness at the time of vaccination.  The NP reported that on 30-AUG-2005, within 24 hours of the vaccinations, the patient developed a fever of 104.8 F with decreased energy and vomiting.  On 01-SEP-2005, the patient was seen by the physician who observed the patient's right arm to be red with one raised papule.  At the time of this report, the patient's fever was down to 100 F and was noted to be 103-104 F for a week prior.  The outcome of the patient's other events was unknown.  Additional information has been requested.
Age: 1.08
Sex: F
Vaccine: MMR
Symptoms: Vomiting
Clinical narrative: Information has been received from a physician and a nurse practitioner (NP) concerning a 13-month-old white female with no known allergies who in approximately March 2002 was vaccinated with the first dose of measles virus vaccine live(+) mumps virus vaccine live (+) rubella virus vaccine live. The physician reported that, eight days after being vaccinated, in approximately April 2002 the patient developed a high fever and rash and was subsequently hospitalized.  Subsequently, the patient's high fever and rash resolved.  On 29-AUG-2005, at approximately 10:00, at 4.5 years of age, the patient was vaccinated SC in the right arm with the second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccinations on that same day included a dose of Diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid.  There was no illness at the time of vaccination.  The NP reported that on 30-AUG-2005, within 24 hours of the vaccinations, the patient developed a fever of 104.8 F with decreased energy and vomiting.  On 01-SEP-2005, the patient was seen by the physician who observed the patient's right arm to be red with one raised papule.  At the time of this report, the patient's fever was down to 100 F and was noted to be 103-104 F for a week prior.  The outcome of the patient's other events was unknown.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Info has been received from a physician concerning a 12 month old male, with no medical history, who in August 2005, was vaccinated with a dose of MMRII. In August 2005, the pt experienced an elevated fever that was greater than 103F. Subsequently, the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Additional info has been requested.
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Info has been received from a physician concerning a female who was vaccinated with a dose of MMRII. In August 2005, the pt developed persistent rash. It was reported that "the rash has been present for more than 5 days". Unspecified medical attention was sought. At the time of the report, the pt had not yet recovered. No product quality complaint was involved. Additional info has been requested.
Age: 1.59
Sex: M
Vaccine: MMR
Symptoms: Blood disorder, Coagulopathy, Rash maculo-papular
Clinical narrative: Info has been received from a physician concerning a 19 month old male with Hemophilia (factor B deficient) and a hematoma on his forehead who on 8/23/05 was vaccinated, SC, in the right thigh with a 1st dose of MMRII (lot 649239/0030R). Concomitant therapy the week of vaccination included anti-hemophilic factor (as drug) for the treatment of the hematoma on his forehead. Illness at the time of vaccination included a viral upper respiratory tract infection. On 9/2/05, the pt developed a generalized measles-like rash. The rash started under his arm and spread to the trunk area. No fever was present. Unspecified medical attention was sought. diphenhydramine tannate (Dytan) was provided to treat the rash. There was no product quality complaint involved. Follow-up info from the physician indicated that on approximately 9/1/05 (previously reported as 9/2/05), 9-10 days after vaccination, the pt developed a maculopapular pink rash on his trunk and proximal extremities. There was no itching, fever, irritability or vomiting. No lab or diagnostic tests were performed. The pt's outcome was recovered. It was noted that the pt had no adverse events following prior vaccination. Additional info is not expected.
Age: 1.0
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Convulsion, Pyrexia, Urticaria
Clinical narrative: Information has been received from a physician concerning a 12-month-old male who was recently vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccinations included a dose of varicella virus vaccine live and a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine.  One week after the vaccinations the patient developed hives, seizures and temperature of 102 degrees Fahrenheit.  Unspecified medical attention was sought and it was reported that the patient was hospitalized for three or more days.  The physician suspected the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live as cause.  No information was reported regarding the present status of the patient.  No product quality complaint was involved.  The physician considered the hives, seizures and temperature of 102 degrees Fahrenheit to be disabling.  Additional information has been requested.
Age: 1.27
Sex: M
Vaccine: MMR
Symptoms: Laboratory test abnormal, Nasal congestion, Pyrexia, Rash erythematous, Rhinorrhoea
Clinical narrative: Information has been received from a physician concerning a 15 month old white male with Down's syndrome and Teralogy of Fallot with primary repair, who on 26-AUG-2005 was vaccinated with a first dose in left anterior thigh of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot6475620579R).  Concomitant vaccine included a dose of varicella virus vaccine live (MSD).  It was noted that the patient's mother reported that the patient had a transient fever of 100-101 with all previous immunization.  In August 2005, the patient experienced an elevated fever that was greater than 103F.  Subsequently, the patient recovered.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  Follow-up information from a physician indicated that the patient had a complete blood cell count on the date of the injection, 26 AUG-2005.  It was reported that on 01-SEP-2005 or 02-SEP-2005 the child became febrile to 104F with nasal congestion, rhinorrhea, and a moderate rose red rash over his torso.  The patient had a complete blood cell count during an emergency room visit at the onset of fever, on 05-SEP-2005.  The event lasted 3-5 days and the patient recovered by 06-SEP-2005.  Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Convulsion, Pyrexia
Clinical narrative: Information has been received from physician concerning a 12-month-old male who was recently vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccinations included a dose of varicella virus vaccine live and a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine.  On the same day of the vaccinations the patient developed a temperature of 103 degrees Fahrenheit and developed seizures.  Unspecified medical attention was sought and it was reported that the patient was hospitalized for three or more days.  The physician suspected the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live as cause.  No information was reported regarding the present status of the patient.  No product quality complaint was involved.  The physician considered the seizures and temperature of 103 degrees Fahrenheit to be disabling.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Convulsion, Nervous system disorder, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 12-month-old male who was recently vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccinations included a dose of varicella virus vaccine live.  Approximately one week after the vaccinations the patient developed a low grade fever and then experienced seizures.  unspecified medical attention was sought and it was reported that the patient was hospitalized for three or more days.  While he was hospitalized tests done indicate " there may have been minimal damage to the brain".  The physician suspected the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live as cause.  No information was reported regarding the present status of the patient.  No product quality complaint was involved.  The physician considered the low grade fever and seizures to be disabling.  Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Rash morbilliform
Clinical narrative: Info has been received from a physician concerning a pediatric pt who on approx. 8/26/05 "two weeks ago" was vaccinated, SC, with an 0.5 ml dose of MMRII. On 9/7/05, the pt developed a measles-like rash. Unspecified medical attention was sought. The pt's outcome was unknown. No product quality complaint was involved. Additional info has been requested.
Sex: U
Vaccine: MMR
Symptoms: Oedema peripheral, Skin hypertrophy
Clinical narrative: Info has been received from an RN concerning a pt who was vaccinated with a dose of MMRII. Subsequently, the pt developed swelling and induration above the elbow in the arm that the injection was given. The reaction was not at the injection site but was in the same arm. Unspecified medical attention was sought. There was no product quality complaint involved. Additional info has been requested.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a nurse practitioner concerning a 16 year old female with no pre-existing allergies, birth defects, or medical conditions, who on 02/27/1990 and 04/03/1992 was vaccinated with a first and second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. There was no illness at the time of vaccination. Subsequently, it was noted that the patient had a negative rubella titer. No other information was available. The outcome was reported as not recovered. Unspecified medical attention was sought. There was no product quality complaint. Follow up information indicated that the third dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live was given 09/16/2005. It was noted the titers were done by gynecology. the outcome was reported as recovered. No additional information is expected.
Sex: U
Vaccine: MMR
Symptoms: Condition aggravated, Convulsion
Clinical narrative: Information has been received from a physician concerning a patient, with a seizure disorder, who was vaccinated once with a 0.5 ml subcutaneous dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  It was reported that the child had a seizure after getting vaccinated.  Subsequently, the patient  recovered.  Unspecified medical attention was sought.  No product quality complaint was involved.  no other information was provided.  upon internal  review, seizure was considered to be an other important medical event.  Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Eczema
Clinical narrative: Info has been received from a case in litigation concerning a male pt who was vaccinated with a dose of MMRII. Subsequently, the pt was dx'd with eczema. No further info is available.
Age: 0.15
Sex: M
Vaccine: DTAPHEPBIP, HIBV, MMR, PNC
Symptoms: Medication error, Oral intake reduced, Pyrexia, Somnolence
Clinical narrative: Info has been received from a mfr. of Pediarix concerning an approximately 8 week old male with a history of breast feeding and who had no pre-existing medical conditions, who in June 2005, was vaccinated with a dose of MMRII. Concomitant vaccines administered on the same day included a 1st dose of Pediarix, a dose of Hib conj vaccine (manufacturer unknown) and a dose of Prevnar. It was noted that the pt received these vaccinations in both hips. Concomitant medications were not reported. In June 2005, the pt spiked a high fever of 103 F, was very sleepy and would not nurse. It was reported that the pt slept most of the following day. The pt was treated with Tylenol. Subsequently, the events resolved on an unspecified date in June 2005. It was noted that a physician or other health care professional has not verified this report. This was originally reported by the pt's mother. Additional info has been requested.
Age: 29.0
Sex: M
Vaccine: MMR
Symptoms: Fatigue, Feeling hot, Syncope vasovagal
Clinical narrative: Information has been received from a registered nurse concerning a 29 year old male with no known allergies and a history of fainting after blood draws, who on 15 September 2005, in the late afternoon, was vaccinated subcutaneously with a 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot# 649675/0240R). There was no concomitant medication. About three minutes post vaccination, the patient began to making a groaning sound and his eyes rolled back into his head. It was noted that his upper body became very stiff, and he was unresponsive. The patient was assisted to the floor. After about one minute, he began to return to normal and slowly oriented to person, place and time. The patient also complained of extreme tiredness and feeling hot. The patient was taken to the emergency room and was released without intervention. The patient's blood sugar was check and found to be within normal limits. Vital signs were stable and an EKG was completed with negative results. The patient was diagnosed as having a vasovagal episode. Subsequently, the patient fully recovered. No product complaint was involved. The reporting registered nurse felt that the event was "in no way related to the vaccination since it occurred within only 3 minutes of receiving the vaccine." Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Laboratory test abnormal, Pyrexia, Rash, Swelling face
Clinical narrative: Info has been received from a physician concerning a 12 month old white male who on 29-AUG-20055 was vaccinated with a 1st, 0.5 ml, SC dose in the left arm of MMRII, (lot 647562/0579R). There was no illness at the time of vaccination. On 9/17/2005, the pt experienced a swollen area in her left cheek. It was noted that an NSAID was given as treatment. Subsequently, the pt recovered. No product quality complaint was involved. No other info was provided. Follow-up info from a physician indicated that on 9/5/05, the pt experienced a fever and a rash. On 9/17/05, the pt experienced a swelling of the left pre-auricular area with no other symptoms. It was reported that the pt recovered. Additional info is not expected.
Age: 44.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning a 45 year old female with unknown medical history and unknown allergies, who on 12/30/2003, was vaccinated subcutaneously with 0.5 ml dose of measles virus vaccine (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # 645404/0269N). On 09/14/2005, the patient's titer was taken and it was negative for rubella. No symptoms were noted. There was no product complaint involved. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a Licensed Visiting Nurse concerning a female (age not reported) who in March 2005, was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot number unknown). Subsequently, on an unspecified date, the patient became pregnant. A titer for rubella as drawn and it was negative for rubella. The patient's LMP and EDD were not reported. No product quality complaint was involved. Follow up information from a health professional indicated that patient did not become pregnant until 4 months following immunization with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. Follow up information from a health professional indicated that the patient follow up with the reporter by telephone only. No other information was available at that time. Additional information is not expected.
Age: 1.16
Sex: F
Vaccine: DTAP, HBHEPB, MMR
Symptoms: Cough, Drug ineffective, Infection, Insomnia, Irritability
Clinical narrative: Information has been received from a mother concerning her 14 month old daughter with no allergies and not medical history, who in "September 2004", was vaccinated with 0.5 ml of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. There was no concomitant medication. The mother reported that "soon after receiving the shot", her daughter became sick for "about 2 weeks", which was described as nausea, fever and a case of the measles. It was reported that the adverse events improved and the patient recovered. There were no laboratory studies completed. There was no product quality complaint reported. Follow up information was received from a physician concerning a 14 month old female with a milk intolerance and a history of allergy testing on 07/01/05, in an allergists office, who on 08/19/04 at 13:58 PM was vaccinated subcutaneously in the right leg with a first 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # 648461/1306N). Concomitant vaccine therapy administered on 08/19/04 at 13:58 PM included a fourth dose of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (Daptacel) (lot # C169AA) administered in the left leg and a second dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (Lot # 648823/0240P) administered in the left leg. It was noted the patient was not ill at the time of vaccination and had not had averse events following prior vaccination. The physician reported that on 08/27/04, the patient experienced fever and swollen glands in the neck. On 09/22/2004, the patient's fever continued, she had irritability, was not sleeping, had congestion, cough and a mouth blister. On 09/24/004, she developed a rash, fever continued and pruritus. Follow up information reported that the patient was seen again on 09/23/04 for fever. It was mentioned that the patient had possible hand, foot and mouth virus. It was noted that the patient recovered on an unspecified date. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.16
Sex: F
Vaccine: DTAP, HBHEPB, MMR
Symptoms: Lymphadenopathy, Nasal congestion, Nausea, Oral mucosal blistering, Pruritus
Clinical narrative: Information has been received from a mother concerning her 14 month old daughter with no allergies and not medical history, who in "September 2004", was vaccinated with 0.5 ml of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. There was no concomitant medication. The mother reported that "soon after receiving the shot", her daughter became sick for "about 2 weeks", which was described as nausea, fever and a case of the measles. It was reported that the adverse events improved and the patient recovered. There were no laboratory studies completed. There was no product quality complaint reported. Follow up information was received from a physician concerning a 14 month old female with a milk intolerance and a history of allergy testing on 07/01/05, in an allergists office, who on 08/19/04 at 13:58 PM was vaccinated subcutaneously in the right leg with a first 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # 648461/1306N). Concomitant vaccine therapy administered on 08/19/04 at 13:58 PM included a fourth dose of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (Daptacel) (lot # C169AA) administered in the left leg and a second dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (Lot # 648823/0240P) administered in the left leg. It was noted the patient was not ill at the time of vaccination and had not had averse events following prior vaccination. The physician reported that on 08/27/04, the patient experienced fever and swollen glands in the neck. On 09/22/2004, the patient's fever continued, she had irritability, was not sleeping, had congestion, cough and a mouth blister. On 09/24/004, she developed a rash, fever continued and pruritus. Follow up information reported that the patient was seen again on 09/23/04 for fever. It was mentioned that the patient had possible hand, foot and mouth virus. It was noted that the patient recovered on an unspecified date. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.16
Sex: F
Vaccine: DTAP, HBHEPB, MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a mother concerning her 14 month old daughter with no allergies and not medical history, who in "September 2004", was vaccinated with 0.5 ml of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. There was no concomitant medication. The mother reported that "soon after receiving the shot", her daughter became sick for "about 2 weeks", which was described as nausea, fever and a case of the measles. It was reported that the adverse events improved and the patient recovered. There were no laboratory studies completed. There was no product quality complaint reported. Follow up information was received from a physician concerning a 14 month old female with a milk intolerance and a history of allergy testing on 07/01/05, in an allergists office, who on 08/19/04 at 13:58 PM was vaccinated subcutaneously in the right leg with a first 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # 648461/1306N). Concomitant vaccine therapy administered on 08/19/04 at 13:58 PM included a fourth dose of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (Daptacel) (lot # C169AA) administered in the left leg and a second dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (Lot # 648823/0240P) administered in the left leg. It was noted the patient was not ill at the time of vaccination and had not had averse events following prior vaccination. The physician reported that on 08/27/04, the patient experienced fever and swollen glands in the neck. On 09/22/2004, the patient's fever continued, she had irritability, was not sleeping, had congestion, cough and a mouth blister. On 09/24/004, she developed a rash, fever continued and pruritus. Follow up information reported that the patient was seen again on 09/23/04 for fever. It was mentioned that the patient had possible hand, foot and mouth virus. It was noted that the patient recovered on an unspecified date. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.56
Sex: U
Vaccine: MMR
Symptoms: Rash morbilliform
Clinical narrative: Information has been received from a physician concerning an 18 month old "healthy" patient who on 03/17/2005, was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot 644981/1235M). There was no concomitant medication. On 03/18/2005, the patient developed a measles like rash. Unspecified medical attention was sought, and the patient was treated with diphenhydramine HCL (Benadryl). Subsequently, the patient recovered. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Irritability, Pharyngitis, Pharyngolaryngeal pain, Rash morbilliform
Clinical narrative: Information has been received from a physician concerning a 12 month old patient with no pre-existing medical conditions or allergies who on 09/15/2005, at 08:30 was vaccinated subcutaneously (also reported as intramuscular) in the left thigh with a 0.5 ml first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (645522/0780P). There was no concomitant medication. The patient was not ill at the time of vaccination. Within the last week, in the morning on 09/24/05, the patient developed fussiness and a sore throat. In the morning of 09/26/05, he developed a truncal rash beginning at the neck and moving down his trunk onto his legs. On 09/26/05, he visited the physician who confirmed the rash origin. It was reported that he had a systemic measles rash, described as multiple erythematous papules (nonconfluent), there were no vesicles and no fever. The patient also had pharyngitis. The physician reported that at first she though it was hand, foot and mouth disease because it has been going around. The physician reported that she could actually see the rash spreading to the entire body. The rash went away the next day (09/27/05). the patient recovered on 09/27/05. The patient did not have adverse events following prior vaccinations. No other additional information was available regarding the adverse event. There was no product quality complaint reported. No additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Respiratory disorder
Clinical narrative: Information has been received from a physician concerning a male who "ten years ago", in 1995, was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. Subsequently, "ten years ago" in 1995, the patient developed respiratory problems. The patient recovered "ten years ago." Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 1.59
Sex: M
Vaccine: MMR
Symptoms: Hypersensitivity, Nasal congestion, Pharyngitis, Rash maculo-papular, Rhinitis
Clinical narrative: Information has been received from a woman working in a physician's office concerning an 18 month old white male with hemophilia, a hematoma on his forehead, and who had underlying allergies, who on 08/23/2005 was vaccinated with a firs subcutaneous dose in the right thigh of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # 649239/0030R). Concomitant therapy included factor VIII, which he had in the last week due to the hematoma on his forehead. It was reported that the patient has had cold symptoms "for about two weeks", since approximately 08/23/05, and developed a rash "yesterday", on 09/01/05. the rash was non-itchy, and he had no fever. It was reported that he has acted fine, not fussy. The patient was alert and calm. Appeared in on distress. He had a viral-appearing exanthem with small reddish/pink, maculopapular lesions scattered over his trunk, with some on his shoulders and proximal extremities. There were no petechiae or vesicles or urticarial lesions. He was moderately congested, and had allergic shiners and Dennie's lines. He had a clear rhinorrhea. There was a small resolving bruise on his forehead. His chest was clear, cardiac was unremarkable, abdomen was benign, joints appeared normal and he moved with obvious discomfort. It was reported that the diagnosis was a rash, probably a measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live reaction, and had underlying allergies. It was not that diphenhydramine tannate (Dytan) suspension was sampled, 1/4 teaspoon, every 12 hours. It was noted that the rash was expected to dissipate, and the patient was to call if there was worsening or new symptoms, swelling of the joints or others. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Hepatomegaly, Splenomegaly
Clinical narrative: Information has been received from a physician via a company representative concerning a patient (age not provided) with unknown medical history and unknown drug allergies who on an unspecified date was vaccinated subcutaneously with 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # unknown). subsequently, the patient developed enlarged liver and spleen. The patient's outcome was not reported. There was no product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Difficulty in walking
Clinical narrative: Information has been received from a consumer concerning his son, who was vaccinated "years ago" with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live and had difficulty walking after the vaccination. No further information is available regarding the adverse event or the patient's outcome. It was unknown as to whether the patient medical attention. There was no product quality complaint reported. Additional information has been requested.
Age: 1.25
Sex: U
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a physician concerning a 15 month old patient ( four year old) who in "approximately 2.75 years ago", was vaccinated SC with a 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Subsequently, the patient developed antibodies to mumps and rubella but not to the measles component of the vaccine.  Unspecified medical attention was sought.  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Anaphylactic reaction
Clinical narrative: Information has been received from a registered nurse concerning a male patient, who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live(+) rubella virus vaccine live.  It was reported that the patient went to an allergist because of an anaphylactic reaction to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  The allergist said that it was " the porcine gelatin that caused the reaction".  The reporter mentioned that the allergist was sure that it was a porcine component that caused the reaction.  No further information regarding the adverse event or the patient's outcome was available.  There was no product quality complaint reported.  The patient sought unspecified medical attention.  Additional information has been requested.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Acne, Rash, Tenderness
Clinical narrative: Information has been received from a physician's assistant concerning a 37 year old female healthcare worker with G6PD immunodeficiency and a meperidine hydrochloride (DEMEROL) allergy, who on 15-OCT-2005 was exposed to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot 6495130935F).  There was no concomitant medication.  It was noted that the healthcare worker was reconstituting the vaccine and was splashed by the vaccine on the left forearm and now has a rash on the left forearm.  It was also noted that there was a " pimple looking papule on her neck".  The rash was tender to the touch with no itching.  She washed her her arm later in the day where the vaccine sprayed her arm.  On 16-OCT-2005 she was diagnosed with contact dermatitis.  Unspecified medical attention was sought.  There were no diagnostic laboratory studies.  She was treated with hydrocortisone cream which has not helped.  At the time of this report, she had not recovered.  No product quality complaint was involved.  No additional information is expected.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Fatigue, Feeling hot, Hypoaesthesia, Injection site nodule
Clinical narrative: Information has been received from a physician concerning a 27 year old female with no known drug allergies and no pertinent medical history who on 15-Sep-2005 was vaccinated (the 1st shot) and 13-Oct-2005 (the 2nd shot) with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (the lot number not reported).  There was no concomitant medication. the first vaccine was no problem. After the second vaccination, on 13-Oct-2005, the patient developed fatigue and warmth.  On 14-Oct-2005 there were nodules, erythema, rash and itching around the injection site.  Then on 15-Oct-2005  her menstrual period began normally and on 16-Oct-2005 she began to develop numbness and paresthesia on her outer vagina and perianal region.  The patient reported that her bowel remained movements felt different and the sensation spread down to her gluteal region.  The vaginal area had remained the same but the gluteal/anal region symptoms had progressed and become worse.  The patient sought unspecified medical attention: no laboratory or diagnostic tests were performed.  It was reported that the patient had not recovered.  There was no product quality complaint involved.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Paraesthesia, Pruritus, Rash
Clinical narrative: Information has been received from a physician concerning a 27 year old female with no known drug allergies and no pertinent medical history who on 15-Sep-2005 was vaccinated (the 1st shot) and 13-Oct-2005 (the 2nd shot) with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (the lot number not reported).  There was no concomitant medication. the first vaccine was no problem. After the second vaccination, on 13-Oct-2005, the patient developed fatigue and warmth.  On 14-Oct-2005 there were nodules, erythema, rash and itching around the injection site.  Then on 15-Oct-2005  her menstrual period began normally and on 16-Oct-2005 she began to develop numbness and paresthesia on her outer vagina and perianal region.  The patient reported that her bowel remained movements felt different and the sensation spread down to her gluteal region.  The vaginal area had remained the same but the gluteal/anal region symptoms had progressed and become worse.  The patient sought unspecified medical attention: no laboratory or diagnostic tests were performed.  It was reported that the patient had not recovered.  There was no product quality complaint involved.
Age: 1.25
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash, Rhinorrhoea
Clinical narrative: Information has been received from a company representative concerning his healthy 15-month-old son with no allergies who on 11-OCT-2005 was vaccinated subcutaneously with a 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  There was no concomitant medication.  On 19-OCT-2005 the patient developed a rash all over his body, low grade fever and runny nose.  It was reported that no medical attention was sought and no laboratory or diagnostic tests were performed.  At the time of the event the patient was also teething with 2 new teeth.  It was reported that the patient was recovering.  No product quality complaint was involved.  Follow-up information has been received from a physician indicating that he did not see the patient for the reaction and no information exists in his outpatient chart.  Additional information is not expected.
Age: 7.0
Sex: M
Vaccine: MMR
Symptoms: Viral infection
Clinical narrative: Information has been received from a physician concerning a 7-year-old male who was  vaccinated with the first and second doses, respectively, of measles virus live (+) mumps virus vaccine live (+) rubella virus vaccine live.  The physician reported that the patient subsequently developed unilateral mumps.  unspecified medical attention was sought.  At the time of this report the outcome was unknown.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Pharyngolaryngeal pain, Vomiting, Weight decreased
Clinical narrative: Information has been received from a health professional concerning her 5 year old son who in October 2005, was vaccinated with a booster dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant therapy included montelukast sodium (MSD).  In October 2005, after vaccination, the patient's throat started to hurt, he was vomiting and he turned red.  He was treated with diphenhydramine hcl (BENADRYL) and cetirizine hydrochloride (ZYRTEC).  As a result of the vomiting, the patient lost weight.  He recovered on 02-OCT-2005.  Unspecified medical attention was sought.  No product quality complaint was involved.
Sex: M
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a male consumer who reported that he had a "mumps and measles vaccine" when he was a child.  It is unknown if he received measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live and whether he received rubella.  He now has a negative titer for rubella.  No medical attention was sought. No product quality complaint was involved. Additional information is not expected.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal, Viral infection
Clinical narrative: Information has been received from a pharmacist concerning a 27-year-old white female with a drug allergy to acetaminophen (+) hydrocodone bitartrate (VICODEN) who works as a hospital discharge planner who on 27-OCT-2005 (also reported as 18-OCT-2005) was vaccinated with a dose of measles virus vaccine vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot6492290149R). On approximately 03-NOV-2005, the patient was diagnosed with an active case of measles.  There was no product quality complaint.  Follow-up information received from a health care professional indicated that on 12-OCT-2005, the patient's rubeola IgG and mumps antibody IgG were negative.  On 27-Oct-2005, the patient developed measles.  On 03-NOV-2005, a rubella titer was positive for IgM antibodies, and an immune IgG rubeola IgM was positive.  The outcome was reported as recovered.  No additional information is expected.
Age: 1.3
Sex: M
Vaccine: DT, MMR
Symptoms: Swelling
Clinical narrative: Info has been received from a physician concerning a 15 month old healthy male with no medical history or allergies who in 11/05, was vaccinated with a dose of MMRII. Concomitant vaccinations on that same day included a dose of DT (unspecified (+) tetanus toxoid. The physician reported that in 12/05, 2 days, post/vax, the pt developed severe diffuse swelling in his leg. Unspecified medical attention was sought. No treatment or lab or diagnostic tests was required. At the time of this report, the pt was recovering from the severe diffuse swelling in his leg. Additional info has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a health professional concerning a 10 year old male with no medical history or allergies who on 10/10/00 was vaccinated with an 0.5 mL 2nd dose of MMRII. There was no concomitant medication. In November 2005, the pt developed mumps. Unspecified medical attention was sought. No lab/diagnostic tests were performed. At the time of the report, the pt was recovering. There was no product quality complaint involved. Additional info has been requested.
Sex: M
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Info has been received from an RN concerning a male child who was vaccinated with the 2nd dose of MMRII. The RN reported that in early 11/05, the pt developed mumps. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. No further info is available.
Age: 32.0
Sex: F
Vaccine: MMR
Symptoms: Feeling abnormal, Laboratory test abnormal
Clinical narrative: Info has been received from a health professional concerning a 32 year old female who on 10/28/05 or 10/29/05 was vaccinated with a dose of MMRII. Shortly after vaccination the pt found out that she was pregnant. It was reported that the pt had a pregnancy test prior to vaccination that was negative. She did not feel well for several days after vaccination. It was reported that she was "less than 8 weeks gestation". Unspecified medical attention was sought. There was no product quality complaint involved. Additional info has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male patient with no allergies and no pertinent medical history, who immigrated from another country, who on 07/18/05 was vaccinated intramuscularly with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (Lot # 649241/0032R). It was noted that the patient was not ill at the time of vaccination. On 08/18/05, the patient had a titer drawn which showed that the patient was immune to measles and rubella but failed to seroconvert and hand no immunity for mumps. It was noted that the same child was vaccinated with varicella virus vaccine live on 08/01/05, and had varicella antibody response failure (WAES#0511USA03158). The reporter indicated that the patient did not have adverse events following prior vaccination. There was no product quality complaint reported. The patient sought unspecified medical attention. No additional information is expected.
Sex: F
Vaccine: MMR
Symptoms: Hypoacusis
Clinical narrative: Info has been received from a physician concerning a teenage pt who was vaccinated with a dose of MMRII as a child and then received it again prior to entering college. The physician noted that the pt reported that when she was collage age, the vaccine gave her hearing loss. At the time of the report, the pt had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Hearing loss was considered to be an Other Important Medical Event (OMIC). Additional info is not expected.